×
Customize
?
Start
Cancer Types
Quick Links
Award Programs
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Combining two immunotherapies known as checkpoint inhibitors along with best supportive care prolonged life by two and a half months in patients with advanced colorectal cancer that resisted previous treatments.
Wayne Kuznar
The experimental oral anticancer regimen known as SM-88, which combines four drugs from different classes, shows promising efficacy and safety with no meaningful toxicity in patients with metastatic pancreatic cancer whose disease worsened despite previous treatment.
Kristie L. Kahl
Prior exposure to PARP inhibitor treatment may not lead to resistance in future use with these agents in women with recurrent epithelial ovarian cancer, meaning repeat use could become more common.
More
Voices
Tamera Anderson-Hanna
On March 9th , CURE® held the first patient portion of the 36th Annual Miami Breast Cancer Conference and I was gratefully in attendance.
Bonnie Annis
Breast cancer is no laughing matter, but being able to find something to laugh about in the midst of the trial can be cathartic.
Kathy LaTour
Of all the things that cancer left me with, scarred veins in my only good arm has been the worst. I have learned to treasure those techs who can find a good vein and hit it the first time.
More
CURE Connections®
Meryl Kaufman, M.Ed., CCC-SLP, BRS-S, and Itzhak Brook, M.D., M.Sc., board members of the Head and Neck Cancer Alliance, provide their perspectives on adjusting to life with cancer of the head and neck, as a patient or as a caregiver, and share advice for those who must undergo laryngectomy.
Meryl Kaufman, M.Ed., CCC-SLP, BRS-S, and Itzhak Brook, M.D., M.Sc., board members of the Head and Neck Cancer Alliance, share insight into the role of novel treatment approaches like immunotherapy, robotic surgery and de-escalation in the management of cancers of the head and neck.
Meryl Kaufman, M.Ed., CCC-SLP, BRS-S, and Itzhak Brook, M.D., M.Sc., board members of the Head and Neck Cancer Alliance, review the various modalities of treatment for cancers of the head and neck and identify which physicians are responsible for delivering this care.
More
Videos
Sponsored Content
Watch a video about Chad, a patient using Optune. Learn how Chad manages his treatment while enjoying his favorite activities.
Alexandra Guadagno
An expert discusses the future of immunotherapy in light of new frontline treatments like Keytruda that have been demonstrating positive results for patients with non–muscle invasive bladder cancer.
Mark Socinski, M.D.
Thanks to better understanding of cancer biology, the outlook for advanced lung cancer is better than it has ever been.
More
Podcasts
Kristie L. Kahl
In this week’s episode, we spoke with Linda Tantawi about Susan G. Komen Greater New York City, and how the organization is connecting communities to educate women about breast cancer.
Kristie L. Kahl
In this week’s episode, we spoke with a patient advocate and survivor of renal cell carcinoma to help raise awareness during Kidney Cancer Awareness month.
Kristie L. Kahl
In this week’s episode, we spoke with actor Scott Foley, who opened up about his experience as a caregiver to his mother after her ovarian cancer diagnosis and why he joined the Not on My Watch movement to help educate others.
More
